Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 540-548

  Khan, Atif J ^a   King, Bonnie L ^a   Smith, Benjamin D ^a   Smith, Grace L ^a   DiGiovanna, Michael P ^a   Carter, Darryl ^a   Haffty, Bruce G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; ONCOGENE NEU; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VALIDATION PROCESS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOKINES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RECEPTOR, ERBB-2; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036190848     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
2. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma
3. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: Correlation with poor prognosis
4. c-erbB-2 expression in squamous cell carcinoma of the head and neck
5. Oral cancer progression and c-erbB-2/neu proto-oncogene expression
6. Cancer Statistics, 1999
7. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma
8. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma
9. Expression of c-erbB-2 gene in human head and neck carcinoma
10. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
11. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinoma
12. Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer
13. Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinoma of the head and neck and the lower female genital tract
14. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
15. Determination of Her-2/neu status in breast carcinoma: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization
16. Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas
17. Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
18. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
19. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
20. The combination of in situ hybridization and immunohistochemical analysis: An evaluation of HER-2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium
21. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
22. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization
23. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma
24. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization
25. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers. Correlation with overall survival
26. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma
27. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization
28. c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aNeusomy in apocrine adenosis of the breast
29. Close or positive margins after surgical resection for the head and neck cancer patient: The addition of brachytherapy improves local control
30. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
31. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck
32. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
33. Immunohistochemical localization of c-erbB-2 in human breast carcinomas
34. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis
35. Neutralizing antibodies against epidermal growth factor and ErbB2/neu receptor tyrosine kinases downregulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
36. Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous cell carcinoma cells
37. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling